Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor J. Kevin Baird

Professor J. Kevin Baird

Podcast interview

Kevin Baird

Professor of Malariology

  • Head of Unit, Eijkman Oxford Clinical Research Unit, Indonesia

Eijkman Oxford Clinical Research Unit

Kevin is Head of Unit at the Eijkman-Oxford Clinical Research Unit (EOCRU). This was created in 2008 by agreement between the Eijkman Institute for Molecular Biolology (EIMB, Ministry of Science & Technology) and the University of Oxford to collaborate on clinical, laboratory, and field research on infectious diseases of clinical and public health importance in Indonesia. EIMB hosts EOCRU as an integrated component of the Institute at its state-of-the-art facility in central Jakarta. EOCRU undertakes joint collaborative research endeavours that bring together partners at EIMB, the Faculty of Medicine Universitas Indonesia (FMUI) and its Indonesia Medical Education and Research Institute (IMERI) in Jakarta. We also engage colleagues at the Faculty of Medicine Universitas Sumatera Utara (FMUSU) at Medan, Faculty of Medicine Universitas Hasanuddin (FMUH) at Makassar, the Faculty of Medicine Universitas Nusa Cendana (FMUNC) at Kupang, as well as the Indonesian Army Health Research Centre (HRC-TNI-AD) in Jakarta. The core work of EOCRU is clinical trials and has involved diagnostics, therapeutics, mosquito vector control, and vaccination interventions relevant to malaria, tuberculosis meningitis, and cryptococcal meningitis. New arrival Dr. Raph Hamers manages the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL) at FMUI and oversees Unit efforts to expand collaborations on infectious diseases in Jakarta and elsewhere. The Unit conducts basic laboratory research on pharmacogenetic issues like glucose-6-phosphate dehydrogenase deficiency and impaired cytochrome P-450 2D6 metabolism, both as related to the treatment of vivax malaria with the drug called primaquine. Dr. Iqbal Elyzar manages the Geospatial Epidemiology group at EOCRU and regularly interacts and collaborates with various Ministries of the Indonesian government with regard to measuring mapping relevant disease burdens and movement of people within Indonesia.  




Soldier Subjects Homecoming

Soldier Subjects Homecoming
About 500 soldiers stand in military formation at a port on Java after disembarking from their transport ship carrying them home after months of duties in remote malarious eastern Indonesia. Almost half of the soldiers standing here have dormant hypnozoites of Plasmodium vivax in their livers --180 of them volunteered for a randomised trial of primaquine against further relapse during one year of follow up on malaria-free Java. The Eijkman Institute of Molecular Biology closely collaborates with the health research services of the Indonesian Armed Forces and EOCRU has helped develop this unique experimental model for a number of trials involving drugs, vaccines, and diagnostics.

Key publications

Recent publications

More publications